Literature DB >> 2114811

Assessment of bronchoalveolar cell and mediator response to isocapnic hyperpnea in asthma.

L B Pliss1, E P Ingenito, R H Ingram, B Pichurko.   

Abstract

The purpose of this study was to test the hypothesis that mediators and cells associated with bronchoconstriction or inflammation are locally synthesized and/or released in the airways of asthmatic subjects in response to isocapnic hyperpnea (ISH). Seven atopic, mildly asthmatic subjects were studied. Baseline measurements were reported previously and included forced expiratory volumes, flow rates, bronchoalveolar lavage (BAL), and methacholine reactivity. Approximately 1 yr later, spirometry and BAL were repeated, but BAL was performed immediately after ISH challenge. As indices of inflammation, BAL measurements were made of eosinophils, neutrophils, epithelial cells, leukotrienes B4, C4, D4, and E4, prostaglandins D2, E2, and F2 alpha, thromboxane B2, histamine, and total protein. Compared with baseline, ISH was associated with higher BAL concentrations of the following: leukotriene B4 (10 versus 121 pg/ml, p = 0.02), leukotrienes C4/D4/E4 (46 versus 251 pg/ml, p = 0.02), eosinophils (0.8 versus 2.2%, p = 0.04), and epithelial cells (2.1 versus 6.1%, p = 0.05). Trends toward significant increases were seen in BAL concentrations of neutrophils and prostaglandin D2. No statistically significant increases were found in BAL measurements of total protein, histamine, prostaglandins E2 or F2 alpha, thromboxane B2, lymphocytes, or macrophages. The magnitude of the response to ISH, as measured by change in FEV1, did not correlate with BAL levels of cells or mediators. This study indicates that ISH, even in mildly asthmatic subjects, is associated with airway increases in a spectrum of bronchoactive mediators and inflammatory cells, supporting the observations of others that antagonists of a single mediator are unlikely to have major clinical effectiveness in ISH or exercise-induced asthma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114811     DOI: 10.1164/ajrccm/142.1.73

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  Airway immunopathology of asthma with exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; Mark W Moody; Moira L Aitken; William R Henderson
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

Review 2.  Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.

Authors:  I K Taylor
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

3.  Inflammatory basis of exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; Mark W Moody; Mark M Wurfel; Lawrence B Schwartz; William R Henderson; Moira L Aitken
Journal:  Am J Respir Crit Care Med       Date:  2005-06-09       Impact factor: 21.405

4.  Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.

Authors:  S M Nasser; G S Bell; R J Hawksworth; K E Spruce; R MacMillan; A J Williams; T H Lee; J P Arm
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

5.  The effect of bronchial blood flow on hyperpnea-induced airway obstruction and injury.

Authors:  A N Freed; C Omori; B H Schofield
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 6.  Exercise-induced bronchoconstriction: pathogenesis.

Authors:  Sandra D Anderson; Pascale Kippelen
Journal:  Curr Allergy Asthma Rep       Date:  2005-03       Impact factor: 4.919

7.  Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma.

Authors:  Joseph M Parker; Chad K Oh; Craig LaForce; S David Miller; David S Pearlman; Chenxiong Le; Gabriel J Robbie; Wendy I White; Barbara White; Nestor A Molfino
Journal:  BMC Pulm Med       Date:  2011-02-28       Impact factor: 3.317

8.  Application of a Cold Dry Air Provocation Test in Pediatric Patients with Asthma.

Authors:  Ji Young Ahn; Bong Seok Choi
Journal:  Children (Basel)       Date:  2022-06-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.